Form 4: ProKidney Corp. Executive Darin J. Weber Sells Shares Under 10b5-1 Trading Plan
SEC Form 4 Filing
Darin J. Weber, Chief Regulatory Officer of ProKidney Corp., sold 16,412 Class A Ordinary Shares at $2.5 per share on September 19, 2024, under a pre-arranged 10b5-1 trading plan.
Summary
- On September 19, 2024, Darin J. Weber, the Chief Regulatory Officer of ProKidney Corp., sold 16,412 Class A Ordinary Shares.
- The sale was executed at a price of $2.5 per share.
- Following the transaction, Weber directly owns 103,480 Class A Ordinary Shares.
- The sale was conducted under a Rule 10b5-1 trading plan adopted on November 20, 2023.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing a stock sale by an executive. It doesn't inherently convey positive or negative sentiment.
Positives
- The use of a 10b5-1 trading plan suggests the sale was pre-planned and not based on insider information.
Industry Context
Sales by company executives are a normal part of corporate activity. The use of a 10b5-1 plan is a common practice to avoid insider trading accusations.
Stakeholder Impact
- The sale of shares by an executive could be perceived negatively by some shareholders, but the existence of a 10b5-1 plan mitigates this concern.
Key Dates
| Date | Description |
|---|---|
| 2023-11-20 | Date the reporting person adopted the Rule 10b5-1 trading plan |
| 2024-09-19 | Date of the transaction (sale of shares) |
| 2024-09-20 | Date of the signature on the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.